--This Year's Biennial Scientific Meeting on Multiple Myeloma Takes Place in Washington, D.C., February 26-March 1--
--Webcasts to Provide Live and On-Demand Coverage of Presentations and Discussions for Patients, Physicians and the Media--
North Hollywood, CA and Washington, D.C. - February 26, 2009 - The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today announced that it will provide complete Internet coverage of the XIIth International Myeloma Workshop in Washington, D.C. The Workshop is the premier myeloma meeting and provides in-depth discussions from the leading experts in the world working in myeloma. The Workshop provides updates on all aspects of myeloma, from the latest advances in basic research to up-to-the-minute discussions of practical treatment strategies involving novel therapies.
For the first time the IMF will provide live streaming Webcasts of these important discussions. The sessions will also be archived for on-demand viewing. The Webcasts can be accessed through the IMF Website, www.myeloma.org.
"The International Myeloma Workshop is the world's premier meeting on multiple myeloma, and we want to be sure everyone can take advantage of the medical developments that will be presented and discussed," said Michael Katz, vice president of the IMF. "Time and distance should not be a barrier for anyone in the myeloma community, including patients, nurses and community physicians, to be able to benefit from this exchange of information and see first-hand the progress that's being made. A highlight of the Workshop is the lively and spirited debates that ensue when experts' opinions differ, and we are pleased to be able to share these debates with the entire myeloma community through our webcasts."
The Webcasts will cover virtually all of the scientific presentations, sponsored symposia and consensus discussions at the Workshop February 26th through March 1st. In addition there will be daily blogs from patient and expert-nursing perspectives.
"This year we expect to hear the latest information on emerging trends, and new drugs in development," said Brian G.M. Durie, M.D., chairman and co-founder of the IMF. "In addition, much of the work begun in myeloma points the way toward progress in treating other blood cancers, so much of this information could be of interest throughout the hematology-oncology community."
Myeloma, also called multiple myeloma, is a cancer of cells in the bone marrow that affect production of blood cells and can damage bone. It cannot be cured, but newer regimens in sequence and combination are providing long-term remissions and good quality of life.
ABOUT the international myeloma foundation
The International Myeloma Foundation is the oldest and largest myeloma organization, reaching more than 185,000 members in 113 countries worldwide.
A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses in four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 200 educational seminars worldwide, maintains a world-renowned hotline, and operates Bank on a Cure®, a unique gene bank to advance myeloma research. The IMF can be reached at (800) 452-CURE. The global Website is www.myeloma.org.
Stephen Gendel and Jennifer Anderson